Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment

Immune checkpoint blockade (ICB) has revolutionized modern cancer therapy, arousing great interest in the neuro-oncology community. While several reports show that subsets of patients with glioma exhibit durable responses to immunotherapy, the efficacy of this treatment has not been observed for uns...

Descripción completa

Detalles Bibliográficos
Autores principales: Arrieta, Víctor A., Dmello, Crismita, McGrail, Daniel J., Brat, Daniel J., Lee-Chang, Catalina, Heimberger, Amy B., Chand, Dhan, Stupp, Roger, Sonabend, Adam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Review Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843050/
https://www.ncbi.nlm.nih.gov/pubmed/36647828
http://dx.doi.org/10.1172/JCI163447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843050/
https://www.ncbi.nlm.nih.gov/pubmed/36647828
http://dx.doi.org/10.1172/JCI163447

Ejemplares similares